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Introduction: Testosterone plays an important role in the blood pressure regulation. However, information with
regard to the effect of this hormone on blood pressure in normotensive and hypertensive conditions is limited.
Therefore, in this study, the relationship between plasma testosterone level and mean arterial pressure (MAP) was
investigated under these conditions. Methods: Normotensive Wistar-Kyoto (WKY) and hypertensive Spontaneous
Hypertensive (SHR) male and female rats were gonadectomized with female rats treated with testosterone. Estrous
cycle stages of intact female rats of both strains were identiﬁed by vaginal smear. Pressure in the carotid artery of
anesthetized rats was measured via direct cannulation technique. The blood was withdrawn for plasma testosterone
level measurement by enzyme-linked immunosorbent assay. Results: Treatment of ovariectomized female WKY and
SHR rats with testosterone for 6-week duration has resulted in MAP to increase (P< 0.05). In male WKY and SHR
rats, MAP and plasma testosterone levels decreased by orchidectomy (P< 0.05). No signiﬁcant differences in MAP
and plasma testosterone levels were observed in intact female WKY and SHR rats between stages of the estrous
cycle. Conclusions: The effects seen in testosterone-treated ovariectomized female rats and in orchidectomized male
rats suggested that testosterone could play an important role in causing the blood pressure to increase.
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Introduction
The relationship between sex steroids and blood pressure has long been observed (22, 48).
Gender difference in the blood pressure regulation has long been documented in which men
have higher blood pressure as compared with age-matched women before menopause (10, 28,
42). Studies have shown that testosterone plays a role underlying the gender difference in
blood pressure regulation. In men, there was an inverse relationship between blood pressure
and plasma testosterone levels (16, 24, 47). Higher plasma testosterone level is associated
with increased blood pressure in males, whereas in females, higher plasma testosterone level
has been associated with increased arterial stiffness (16, 45). In addition, there is increased
risk of hypertension in women possessing high plasma testosterone levels as in polycystic
ovary disease (3, 12).
The effects of testosterone on blood pressure regulation have been documented in
animals. In hypertensive rats, the levels of testosterone correlate with the mean arterial
pressure (MAP) (10, 15, 23, 27, 37). However, in some studies, testosterone was found to
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have no effect on the blood pressure (8, 17). The effects of sex-steroid hormones on blood
pressure in females are far more complex and less well understood as compared with the
effects of these hormones on blood pressure in males. Female blood pressure was found to be
inﬂuenced by estrogen (9, 18, 46).
To date, there have been limited ﬁndings with regard to the effect of testosterone on
blood pressure regulation in females. The levels of this hormone were found to ﬂuctuate
throughout female reproductive cycle, which suggested that testosterone could inﬂuence the
blood pressure as there is a mild blood pressure ﬂuctuation observed throughout the cycle
(26, 39, 40). In this study, the effects of testosterone on blood pressure regulation in females
were investigated. In addition, the effects of removal of endogenous testosterone on blood
pressure regulation in males were also investigated. Furthermore, inﬂuence of testosterone on
blood pressure throughout the female reproductive cycle was also identiﬁed.
Materials and Methods
Animals
Eight-week-old male and female Wistar-Kyoto (WKY) and Spontaneous Hypertensive
(SHR) rats were maintained in a well-equipped animal facility with a constant 12:12 h
light:dark cycle. All animals had free access to a standard rodent chow diet (Teklad Diet,
Rossdoff, Germany) and tap water ad libitum. All procedures were approved by the
Institutional Animal Care and Use Committee (IACUC), University of Malaya with ethics
number: 2014-05-07/physio/R/NS.
Experimental designs
In this study, three different experiments were designed and performed independently as
follows:
Experiment 1. Male and female WKY and SHR rats were divided into four groups, each
group contains ﬁve rats. Sham operations, orchidectomies, and ovariectomies were per-
formed at 8 weeks of age in a sterile environment. At 16 weeks of age, animals were subjected
for subsequent procedures. Experimental groups were designed as follows:
Group 1: Sham-operated, intact male WKY and SHR rats
Group 2: Orchidectomized (ORX), male WKY and SHR rats
Group 3: Sham-operated, intact female WKY and SHR rats
Group 4: Ovariectomized (OVX), female WKY and SHR rats
Experiment 2. Female WKY and SHR rats were used in this experiment. All animals were
subjected for vaginal smear examination at 16 weeks of age. 0.9% (w/v) NaCl was ﬂushed
into the vagina and the ﬂuid was then retrieved. Estrous cycle stage was determined based on
the cells found in the vaginal ﬂushing (unstained). The criteria for estrous stages identiﬁcation
were as described by Marcondes et al. (29). All rats were grouped in accordance with the
estrous cycle stages, with ﬁve animals per group. Four experimental groups per strain were
designed as follows:
Group 1: Proestrus stage (Ps)
Group 2: Estrus stage (Es)
Group 3: Metestrus stage (Ms)
Group 4: Diestrus stage (Ds)
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Experiment 3. Male and female WKY and SHR rats were divided into four groups, each
group contains ﬁve animals. Sham operations, orchidectomies, and ovariectomies were
performed at 8 weeks of age. All surgeries were performed under sterile conditions.
A group of ovariectomized female rats were implanted with testosterone 2 weeks after
recovery for 6 weeks. For chronic testosterone administration, a 19-mm-long silastic
tubing (Dow Corning Corporation, Auburn, MI; 0.062 in. ID; 9.125 in. OD) containing
10 mg of testosterone propionate (Sigma-Aldrich, St. Louis, MO, USA) was implanted
subcutaneously at the back of the rat shoulder, following the method as described by
Reckelhoff et al. (36). Non-testosterone-treated rats were implanted with empty silastic
tubing. The tubings were replaced every 3 weeks. When animals achieved 16 weeks of age,
they were subjected for the procedures. Four experimental groups per strain were designed
as follows:
Group 1: Sham-operated, intact male WKY and SHR rats
Group 2: Orchidectomized (ORX) male WKY and SHR rats
Group 3: Ovariectomized (OVX) female WKY and SHR rats
Group 4: Ovariectomized (OVX) and testosterone-treated (T) female WKY and
SHR rats
In vivo blood pressure measurement
Rats were anesthetized at 16 weeks of age by pentobarbital sodium anesthesia (60 mg/kg;
Sigma-Aldrich), which was injected intraperitoneally and the dose was maintained
throughout the period of anesthesia. Cannulation of the carotid artery follows the method
as described by Parasuraman and Raveendran (34). In brief, a small incision was made in
the trachea to insert a tracheostomy tube and a cannula pre-ﬁlled with heparinized normal
saline (0.5 IU/ml) was then inserted into the artery. The cannula was connected to a
PowerLab Data acquisition system (ADInstruments, Australia), which then directly
monitors the blood pressure. Blood pressure was recorded after the rats were stabilized
at least for 10 min. Data were analyzed by LabChart version 6.0 where the average systolic
blood pressure (SBP) and diastolic blood pressure (DBP) were obtained. MAP was then
calculated.
Measurement of plasma testosterone level
At the end of cannulation, blood was collected from the artery and placed into a chilled
heparinized tubes. Blood plasma was obtained by centrifuging at 3,000 × g for 20 min at 4 °C.
Plasma testosterone levels were measured using enzyme-linked immunosorbent assay kit
(Enzo Life Sciences, Farmingdale, NY, USA) (Cat No. ADI-900-065), following the
manufacturer’s guidelines. Each assay was performed in triplicate with the lowest
sensitivity limit of 5.67 pg/ml.
Statistical analysis
All data were presented as mean± standard error of mean (SEM). All statistical analyses were
performed using GraphPad Prism (GraphPad Software Inc., San Diego, CA, USA). Statistical
differences between groups were evaluated using independent unpaired Student’s t-test.
Comparisons between more than two groups were performed using one-way analysis of
variance with Tukey’s post-hoc test. Differences were considered as statistically signiﬁcant at
P level< 0.05.
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Results
Effects of gonadectomy on MAP and plasma testosterone level in males and female rats
In sham-operated male rats, MAP was higher than sham-operated female rats for both rat
strains (P< 0.001) (Fig. 1a). Orchidectomy caused a decrease in MAP in male rats (P< 0.01
for WKY rats and P< 0.001 for SHR rats). In female rats, ovariectomies also caused a
decrease in MAP (P< 0.05 for WKY rats and P< 0.01 for SHR rats).
The highest plasma testosterone levels were observed in sham-operated male SHR rats
(Fig. 1b). Orchidectomy decreased the plasma testosterone level in both male WKY
(P< 0.001) and SHR (P< 0.05) rats. Similarly, ovariectomy also decreased the plasma
testosterone level in female rats of both strains (P< 0.05).
Changes in MAP and plasma testosterone levels at different stages of the rat estrous cycle
No differences in MAP were reported across the estrous cycle stages for any of the WKY and
SHR female rats (Fig. 2a). Similarly, plasma testosterone levels were not signiﬁcantly
different between stages of the estrous cycle in any of the rat strains (Fig. 2b).
Effects of testosterone on MAP and plasma testosterone levels in female rats
In ovariectomized female rats, 6-week treatment with testosterone caused the MAP to
increase (P< 0.05 for WKY rats and P< 0.01 for SHR rats) (Fig. 3a). In concordant, plasma
Fig. 1. (a) MAP of 16-week-old
WKY and SHR male and female
rats as measured by cannulation of
the carotid artery. Sham operation
and gonadectomies were carried
out at 8 weeks of age. (b) Plasma
testosterone levels were measured
using the blood collected from the
carotid artery at the end of the
experiment. Data were presented
as mean± SEM; n= 5/group;
*P< 0.05; **P< 0.01;
***P< 0.001. Sham: sham-
operated; ORX: orchidectomized;
OVX: ovariectomized
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testosterone levels in female rats receiving testosterone treatment markedly increased
(P< 0.05) (Fig. 3b).
Discussion
Sex steroids are known to play an important role in the blood pressure regulation in males and
females (19, 21, 28). In this study, a positive correlation between plasma testosterone level
and MAP has been identiﬁed. MAP was found to be higher in intact male WKY and SHR rats
as compared with intact female WKY and SHR rats and these ﬁndings were consistent with
the reports by others (4, 7, 30, 31, 35). In this study, gonadectomies performed prior to
pubertal age, that is, 8 weeks were found to decrease the MAP in both male and female
normotensive WKY and SHR rats. These ﬁndings were also consistent with the report by
Masubuchi et al. (31) who showed that the blood pressure in adult male and female rats could
be affected by gonadectomies. In male rats, it was found that orchidectomy caused a decrease
in the levels of endogenous testosterone, whereas in female rats, ovariectomy caused a
decrease in endogenous testosterone levels.
Changes in plasma testosterone levels were found to positively correlate with MAP, as
seen in male and female intact and gonadectomized rats and in gonadectomized female rats
receiving exogenous testosterone treatment. The increase in MAP in ovariectomized female
Fig. 2. (a) MAP of 16-week-old
naive female WKY and SHR rats
as measured by cannulation of the
carotid artery. The stages of
estrous cycle were determined by
vaginal smears. (b) Plasma
testosterone levels were measured
using the blood collected from the
carotid artery at the end of the
experiment. Data were presented
as mean± SEM; n= 5–8/group.
Ps: proestrus; Es: estrus; Ms:
metetrus; Ds: diestrus
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rats of both strains following exogenous testosterone treatment strengthened the argument
that testosterone increases the blood pressure as this model eliminates the effect of male sex
chromosome, which has been implicated in causing higher blood pressure in males
compared with females (13, 14, 32). Our ﬁndings were supported by the results of
Reckelhoff et al. (36) who demonstrated an increase in MAP in testosterone-treated female
SHR rats. In this study, increase in MAP was also seen in testosterone-treated normotensive
WKY rats, indicating that testosterone-induced increase in blood pressure could also
happen in the normotensive condition. The ﬁndings in male WKY and SHR rats in which
orchidectomy had also caused a decrease in blood pressure have further strengthened the
view that testosterone is involved in increasing the blood pressure, a ﬁnding similar to that
found by others (23).
There were conﬂicting reports with regard to the effect of ovariectomy on MAP (9, 35,
42). Ovariectomy has been reported not to cause changes in blood pressure of wild-type mice.
In another study using Sprague-Dawley (SD) rats at 10–12 weeks of age, no difference in the
MAP between intact and ovariectomized female rats was found (49). In another study,
Crofton and Share (6) have shown that in female SD rats, gonadectomy did not cause
signiﬁcant changes in blood pressure when compared with intact rats. Their study further
showed that gonadectomized female rats were more sensitive toward deoxycorticosterone-
salt induced increase in the blood pressure. Ovariectomy performed in 6-week-old female
Dahl salt-sensitive rats which were given low-sodium diet did not cause any signiﬁcant
changes in blood pressure at 12 weeks (3 months), however at 16 weeks (4 months), the SBP
in these rats was signiﬁcantly higher than in intact rats, and these differences persisted up to
the age of 84 weeks (12 months) (20).
Fig. 3. (a) MAP of 16-week-old
WKY and SHR male and female
rats as measured by cannulation of
the carotid artery. Sham operation
and gonadectomies were
performed at 8 weeks of age. At
the age of 10 weeks, female rats
were treated with testosterone
implants for 6 weeks. (b) Plasma
testosterone levels were measured
using the blood collected from the
carotid artery at the end of the
experiment. Data were presented
as mean± SEM; n= 5/group;
*P< 0.05; **P< 0.01;
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In contrast, our ﬁndings and several other ﬁndings indicated that ovariectomy reduced
the blood pressure in female rats. Stachowiak et al. (44) reported that 28 days after
ovariectomy, the blood pressure in female rats markedly decreased which was associated
with a marked atrophy of the adrenal cortices. A recent study also indicated that there was a
trend of a reduction of the blood pressure taken at 24 weeks of age in female SD rats where
ovariectomy was performed at 7 weeks of age (5). A study conducted in 12-week-old Wistar
rats indicated that there was a transient decrease in MAP measured using a tail cuff, 2 weeks
after ovariectomy which subsequently returned to pre-ovariectomized values (25). In this
study, we measured the blood pressure in anesthetized female rats via carotid artery
cannulation which showed similar results.
We hypothesized that the decrease in MAP following ovariectomy in female WKY and
SHR rats may be, at least partly, mediated by suppression of adrenal secretory activity, due to
the lack of circulating estrogens, which are known to stimulate the hypophyseal adrenocorti-
cotropic hormone release. Estrogen has been reported to be able to increase the rennin–
angiotensin system activity (33, 41). Therefore, a decrease in estrogen levels following
removal of endogenous source of estrogen via ovariectomy will result in the alleviation of
estrogen-induced increase in renin–angiotensin–aldosterone system activity, contributing to
the reduction in blood pressure.
This study has shown that there was no signiﬁcant difference in MAP during the rats’
estrous cycle. Previous studies have also demonstrated that blood pressure did not change
throughout the estrous cycle in rodents (2, 11). Liu and Ely (27) also reported that the blood
pressure in female SHR rats did not change throughout the estrous cycle, a ﬁnding consistent
with ours. The fact that there were no changes in blood pressure observed throughout the
estrous cycle indicated that ﬂuctuation in endogenous sex-steroid levels throughout the cycle
had no inﬂuence on the blood pressure. Despite the high estrogen levels at estrus and high
progesterone levels at diestrus, these hormones seem not to have an inﬂuence on the blood
pressure. On the other hand, plasma testosterone levels did not change signiﬁcantly
throughout the estrous cycle (40). Therefore, it can be concluded that in intact female rats,
the blood pressure changes rather depend on other factors than the ﬂuctuating levels of sex-
steroid hormones.
This study has several limitations. The blood pressure measurements made in anesthetized
rats might not reﬂect the changes in blood pressure of conscious animals. Future studies should be
performed using a radio-telemetry device that can provide a real-time blood pressure monitoring
in conscious, freely moving animals (1). In conclusion, this study may have implications in the
understanding of gender difference in blood pressure regulation. Testosterone might be impli-
cated in causing higher incidence of hypertension in men, and in women after menopause (38).
The elevated MAP in post-menopausal women could partly be related to the elevated levels of
plasma testosterone, in addition to the falling levels of plasma estrogen (43, 50).
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